FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer - OncoDaily FDA approves niraparib plus abiraterone and prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer based on AMPLITUDE trial data.

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

@fda.gov

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC

An Add-On Improves Treatment for Resistant Prostate Cancer Changes in BRCA1 or BRCA2 genes can reduce DNA repair and make cancer recovery difficult. Now men with resistant prostate cancer have a promising treatment option.

Add-On Treatment for Resistant Prostate Cancer
Changes in BRCA1 or BRCA2 genes can make cancer recovery difficult. Now there's a promising treatment option. bit.ly/4hHmX7P @ipcr.bsky.social @naturemedicine.bsky.social #prostatecancer #BRCA #Niraparib #ProstateSupport @pcr-uk.bsky.social

Clinical trial shows biomarkers hold clue in treating aggressive prostate cancer – BioNews Central A Phase 2 clinical trial identified potential reasons for high recurrence rates in aggressive prostate cancer and suggests targeted therapy as a hopeful treatment option. ...

A Phase 2 #ClinicalTrial identified potential reasons for high recurrence rates in #AggressiveProstateCancer and suggests #TargetedTherapy as a hopeful treatment option. 
#ProstateCancer #Biomarkers #ProstateCancerTreatment #Niraparib #ASCO25

PhD student Tao Xie from our group presenting her research at #ANZGOG2025ASM this week on discovering new ways to address acquired resistance to #PARPinhibitors in #OvarianCancer. A bustling poster session! #High-GradeSerousOvarianCancer #DrugResistance #olaparib #niraparib 🧪

Niranib 100mg (Niraparib) | Buy Medicine Online At IEB Pharma The absolute bioavailability of Niranib 100mg (Niraparib) is approximately 73%. Following oral administration of Niraparib, peak plasma concentration.

Niranib 100mg, containing the active ingredient Niraparib, is primarily prescribed for the treatment of ovarian cancer.
#Niranib100mg #Niraparib #Medicine #Health #OnlineMedicine #MedicineStore #AntiCancer #LiverCancer
iebpharma.com/product/nira...